DEVELOPMENT OF A CALCIUM OXALATE UROLITHIASIS MODEL WITH DAMP-HEAT DOWNWARD FLOW SYNDROME IN WISTAR RATS

Thi Nhu Quynh Nguyen1,2, , Thanh Ha Tuan Nguyen1, Ngoc Bich Son Le1,3, Thi Thanh nhan Tran1, Van Giap Ha1, Hoang Ngan Nguyen1
1 Vietnam Military Medical University
2 Phenikaa University
3 Traditional Medicine Administration

Main Article Content

Abstract

Objectives: To develop a calcium oxalate urolithiasis model with damp-heat downward flow syndrome in Wistar rats. Methods: An randomized controlled experimental study was conducted on 30 Wistar rats, randomly divided into 3 groups (n = 10): Group 1 (the control group): Received distilled water; group 2 (the urolithiasis group): Received an oral solution of ethylene glycol (EG) 0.75% (v/v) and ammonium chloride (AC) 2% (w/v) in drinking water; and group 3 (the urolithiasis combined with damp-heat downward flow syndrome group): Received the same lithogenic treatment combined with a humid-heat environment, a high-lipid diet, and restricted activity. The modeling period lasted 28 days. Body weight, urinary biochemical parameters, hematological indices, renal function indices, inflammatory cytokines, gross renal findings, and renal histopathology H&E staining were evaluated. Results: Rats in the model groups showed lower weight gain compared with the control group. Urinary oxalate, calcium, phosphate, serum creatinine, blood urea nitrogen (BUN), CRP, IL-6, and TNF-α increased, whereas urinary pH decreased significantly. Calcium oxalate crystals were detected in 80% of rats in group 2 and 100% in group 3. Histopathological examination revealed calcium oxalate crystal deposition in renal tubules. Conclusion: The calcium oxalate urolithiasis model combined with damp-heat downward flow syndrome was successfully established.

Article Details

References

1. Siener R, Herwig H, Rüdy J, Schaefer RM, Lossin P, Hesse A. Urinary stone composition in Germany: results from 45,783 stone analyses. World J Urol. 2022;40:1813-20. doi:10.1007/s00345-022-04060-w
2. Jiang C, Wang L, Wang Y, Xu R, Yang H, Peng J. Therapeutic effects of Chinese herbal medicines for treatment of urolithiasis: a review. Chin Herb Med. 2023;15(4):526-32. doi:10.1016/j.chmed. 2023.09.001
3. Patel MK, Raval SK, Modi RJ, Sadhu DB, Gehani MT. Nephroprotective effect of herbal seed extracts of Vigna unguiculata and Hordeum vulgare on serum biochemical changes on ethylene glycol and ammonium chloride induced urolithiasis in female Wistar rats. Int J Curr Microbiol App Sci. 2018;7(9):2977-85. doi:10.20546/ijcmas.2018.709.370
4. Sakthikarthikeyan S, Ramesh S, Senthilkumar P, Priya K, Srinivasan MR, Balagangatharathilagar M, et al. A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods. J Pharmacol Toxicol Methods. 2025;133:107743. doi:10.1016/j.vascn.2025.107743
5. Chen SJ, Chiu KY, Chen HY, Lin WY, Chen YH, Chen WC. Animal models for studying stone disease. Diagnostics (Basel). 2020;10(7):490. doi:10.3390/ diagnostics10070490
6. Yao W, Yang C, Wen Y, Zhang W, Zhang X, Ma Q, et al. Treatment effects and mechanisms of Yujin Powder on rat model of large intestine dampness- heat syndrome. J Ethnopharmacol. 2017;202:265-80. doi:10.1016/j.jep.2017. 03.030
7. Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3(3):256-76. doi:10.3978/j.issn. 2223-4683.2014.06.04
8. Wigner P, Grębowski R, Bijak M, Szemraj J, Saluk-Bijak J. The molecular aspect of nephrolithiasis development. Cells. 2021;10(8):1926. doi:10.3390/cells10081926